Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
Source: Finance News Network
21 Nov 2019 - Alpha HPA (ASX:A4N) Managing Director, Rimas Kairaitis provides an update on the company's High Purity Aluminum (HPA) processing technology, pilot plant program and project economics.
Read More14 Dec 2021 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's $2.7m share placement, as well as recent deals with NEC and Panasonic.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More19 Jun 2023 - Industry standard graphite anodes have reached their technical limitations. AnteoTech Limited (ASX:ADO) CEO and Managing Director David Radford discusses the company's solution for significantly increasing battery capacity by enhancing silicon integration.
Read More16 Sep 2024 - Quantum Brilliance CEO Mark Luo discusses how his company is pioneering quantum computing with synthetic diamonds, offering a miniaturised and energy-efficient alternative. He highlights the company's rapid growth since its spin-out from the Australian National University, its unique approach to quantum technology and the enormous commercial potential of quantum at the edge.
Read More25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Iggy Tan, Managing Director of Altech Batteries (ASX:ATC).
Read More07 Dec 2020 - ResApp Health Limited (ASX:RAP) CEO and Managing Director Dr Tony Keating provides an update on the company's growing suite of apps for the diagnosis and management of respiratory conditions and sleep apnoea, discussing its launch of the ResAppDx smartphone-based acute respiratory diagnostic test.
Read More24 Nov 2020 - Imdex (ASX:IMD) Limited CEO Paul House discusses the company's financial update, outlook and strategy, and provides an introduction to its technology, which improves the productivity of drill rigs, data collection and analysis.
Read More23 Sep 2019 - SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director & CEO, Stephen Carter discusses the company's portfolio and the benefits of reformulating and delivering medication through the oral mucosa.
Read More21 Oct 2019 - Kingston Resources Limited (ASX:KSN) CFO, Chris Drew, provides an update on the company's Misima and Livingstone gold projects and drill program.
Read More
